Esophageal cancer
Conditions
Interventions
Nutritional Intervention (oralintake of HINEX)
Sponsors
Yamaguchi University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: *Patients who undergo preoperative chemotherapy for resectable esophageal cancer *Be able to ingest orally *Age more over 20 years *No gender *Eastern Cooperative Oncology Group performance status (ECOG PS) of 1 or less *Adequate baseline organ function *written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: *contraindications to HINEX *Major complications or active concurrent malignancies *Mental illness *Diabetes treated with insulin *History of drug allergy or difficulty ingesting 5-FU or Cicplatin *Pregnancy or lactation, or intending to conceive *Being assessed by the physician in charge as not appropriate to enter the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of preoperative sarcopenia | — |
Secondary
| Measure | Time frame |
|---|---|
| Nutritional assessment, Adverse events of chemotherapy, Antitumor effects, Inflammatory findings, Incidence of infectious complications | — |
Countries
Japan
Contacts
Public ContactShinsuke kanekiyo
Yamaguchi University Graduate School of Medicine Department of Gastroenterological, Breast and Endocrine Surgery
Outcome results
None listed